In addition, plasma from tumor-free, anti-PD1-treated mice enhanced cell motility of EMT6, RET and B16 cells, as demonstrated by faster wound closure in a scratch wound assay (figure 1B), suggesting that host-secreted factors, rather than tumor-secreted factors, are mostly responsible for the tumor cell aggressive effects. This evidence concerns the gene PDCD1 and neoplasm.